Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thrombosis is the pathological formation of a blood clot (thrombus) within a blood vessel, which can obstruct blood flow and lead to serious complications such as tissue ischemia or infarction (StatPearls, 2023). It is not a single molecular target but a complex physiological process involving the activation of platelets and the coagulation cascade (NIH, 2024). The condition is traditionally categorized into venous and arterial thrombosis, each with distinct triggers and clinical presentations like deep vein thrombosis or myocardial infarction. Therapeutic strategies do not target thrombosis directly as a molecule but instead inhibit specific components like Factor Xa, thrombin, or platelet receptors to prevent clot expansion or formation. Managing thrombosis requires a careful balance between preventing pathological clots and maintaining normal hemostasis to avoid life-threatening bleeding (PubMed, 2022). Biomarkers such as D-dimer and coagulation assays are frequently used to monitor the state of the thrombotic process and the efficacy of treatment.
Thrombosis is a pathological process rather than a single molecular target; pharmacological intervention involves anticoagulation (inhibiting clotting factors like Factor Xa or Thrombin), antiplatelet activity (inhibiting platelet aggregation), or thrombolysis (enzymatic degradation of fibrin clots).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thrombosis.